France Blister Packaging Market Size, Share, Opportunities, And Trends By Type (Compartment, Slide, Wallet), By Material (PVC, PVDC, PP, Others), By Technology (Cold-Form, Thermoformed), And By End-User (Consumer Goods, Food, Pharmaceutical) - Forecasts From 2023 To 2028

The France blister packaging market is projected to witness a compound annual growth rate of 2.47% to grow to US$437.804 million by 2028, from US$369.065 million in 2021.

One of the main causes of the gradual adoption of blister packaging in the pharmaceutical industry has been the prevalence of fake medications in the nation. Further, the demand for prescription and over-the-counter medications is expected to increase steadily as more French people spend money on their healthcare requirements.

The rising trend of short-cycle medicine, greater patient adherence, rising off-patenting of medications, and unit-dosing regulations are driving factors in the France blister packaging industry. All of these elements are anticipated to increase blister packaging demand in France in the pharmaceutical packaging business.

According to OEC data, France became the sixth-largest importer of special pharmaceuticals in the world in 2021, bringing in $556M. Special Pharmaceuticals was France's 259th most-imported product in 2021. Special pharmaceuticals are mostly imported by France from Germany ($112M), Belgium ($86.6M), the Netherlands ($57.4M), Italy ($55.2M), and Ireland ($47.8M). Between 2020 and 2021, Belgium ($25.2M), Germany ($18.8M), and Austria ($5.85M) had the fastest-growing import markets for Special Pharmaceuticals for France. The growth is anticipated to significantly impact the blister packaging market in France.

Benefits of Blister Packaging

Blister packaging's main objective is to preserve the integrity of the product, although efforts are still being made in all facets of the packaging business to save costs throughout the packaging process. To assure the optimum protection for pharmaceutical applications like tablets and capsules, Amcor's Polybar barrier film product families offer a wide range of moisture barriers in addition to having strong crush resistance. It uses various materials including Aclar, COC, PE, PVC, and PVDC.

The market for blister packaging in France is expanding because of emerging trends including senior-friendly features, RFID-enabled medication compliance, pressure-sensitive push-through blisters (AOF), and CR packaging with an anti-lock mechanism.

Growing Healthcare Expenditure and Product Development

Pharmaceutical businesses have started using outsourcing as a result of growing healthcare costs and a broadening demand for pharmaceutical products worldwide. To produce pharmaceuticals on a wider scale, contract development manufacturing Active pharmaceutical ingredients (API), medicinal product development, and packaging services are all offered by contract development and manufacturing companies.

As French people are becoming more health aware, manufacturers are focusing on product innovation and development, which is significantly fueling the healthcare expenditure in the nation. For instance, according to World Bank Data, France's healthcare expenditure increased from 11.09% of the GDP in 2019 to 12.02% in 2020. The surge in healthcare expenditure fuels the use of blister packaging in the region.

The use of blister packaging in Pharmaceuticals

Blister packaging is a pre-formed plastic packaging that uses thermoplastic such as polyvinyl chloride (PVC) or polyethylene terephthalate (PET) as packaging material. The ability of such packaging types to preserve product integrity has enabled it to find major usage in pharmaceutical packaging. Growing chronic disease prevalence has propelled the medicine demand in France thereby increasing the overall healthcare expenditure which is expected to positively impact the blister packaging usage in France’s pharmaceutical sector. For instance, according to the LEEM (France Pharmaceutical Industry Association), France’s retail pharmacy sales in 2020 reached €21.2 billion which represented a 1.9% increase over 2019.

According to the European Federation of Pharmaceutical Industries and Association, in 2021, Pharmaceutical production in France reached €23,557 million and as per the same source, the research and development in the country’s pharmaceuticals sector stood at €4,451 million. Also, as per the Eurostat data, healthcare expenditure accounted for 12.4% of the total France’s GDP in 2021 which signified a 10.7% increase over 2010’s healthcare spending.

Besides the pharmaceutical sector’s steady growth, the well-established presence of market players such as Laboratoire Diephez which provides more than 150 blister pack formats for pharmaceutical packaging in France and produces over 50 million blister packs a year is acting as an additional driving factor for France blister packaging market growth.

Key Developments

• In April 2023, MAX Solutions, Inc., a unique specialized packaging platform established in 2021, presented MAX EcoblisterTM, a cutting-edge, greener option to plastic blister packs.
• In April 2021, Amcor announced client trials for the recyclable thermoform blister packaging made of polyethylene. The new packaging offers a more environmentally friendly substitute for the most popular kind of healthcare packaging while still meeting the strict specifications of highly specialized and regulated pharmaceutical packaging.
• In September 2022, Amcor received the 'Recyclable Packaging' category award at Packaging Europe's 2022 Sustainability Awards. The business received recognition for its ground-breaking vinyl- and aluminum-free thermoformed blister technology, Amcor HealthCareTM AmSkyTM.
• In July 2023, Constantia Flexibles, a leading packaging company in France introduced REGULA CIRC for environmentally conscious pharmaceutical blister packaging for applications requiring a total barrier, designed for recycling cold-form foil.
• In November 2021, New packaging for 30-count blister card packets (blister packs) of SANDIMMUNE® (cyclosporine capsules, USP) 100 mg soft gelatin capsules were made available, according to Novartis Pharmaceuticals Corporation (Novartis).

France Blister Packaging Market Scope:

Segmentation:

• By Type
  • Compartment
  • Slide
  • Wallet
• By Material
  • PVC
  • PVDC
  • PP
  • Others
• By Technology
  • Cold-Form
  • Thermoformed
• By End-User
  • Consumer Goods
  • Food
  • Pharmaceuticals

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY  

2.1. Research Data

2.2. Assumptions

3. EXECUTIVE SUMMARY

3.1. Research Highlights

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porters Five Forces Analysis

4.4. Industry Value Chain Analysis

5. FRANCE BLISTER PACKAGING MARKET, BY TYPE

5.1. Introduction

5.2. Compartment

5.3. Slide

5.4. Wallet

6. FRANCE BLISTER PACKAGING MARKET, BY MATERIAL

6.1. Introduction

6.2. PVC

6.3. PVDC

6.4. PP

6.5. Others

7. FRANCE BLISTER PACKAGING MARKET, BY TECHNOLOGY

7.1. Introduction

7.2. Cold-Form

7.3. Thermoformed

8. FRANCE BLISTER PACKAGING MARKET, BY END-USER

8.1. Introduction

8.2. Consumer Goods

8.3. Food

8.4. Pharmaceuticals

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Vendor Competitiveness Matrix

10. COMPANY PROFILES

10.1. Novartis France

10.2. Nelipak

10.3. Uhlmann Group

10.4. Sonoco Products Company

10.5. WestRock

10.6. Strobel GmbH

10.7. Constantia Flexibles

10.8. Schreiner Group

10.9. Laboratoire Diephez

Novartis France

Nelipak

Uhlmann Group

Sonoco Products Company

WestRock

Strobel GmbH

Constantia Flexibles

Schreiner Group

Laboratoire Diephez